chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: . The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization, reaction(s): "sick"; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization, reaction(s): "sick"; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for Covid-19 immunization, reaction(s): "sick". The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "vaccine & 2 boosters made me very sick".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv vax 16JUN97 & 5 days later 21JUN97 pimples on neck & forehead which tended to sting;these lesions resolved w/in 2 days w/o tx;
This spontaneous report was received from a nurse via company representative referring to a 5 year old female patient who in August 2013, vaccinated with PROQUAD (Merck) (lot # J005179, expiration date 03-NOV-2014). In A2013 the patient experienced developed a rash around the injection site. The outcome of developed a rash around the injection site was reported as recovered/resolved. {Additional information has been requested. / Additional information is not expected.} The nurse reported that the patient developed a rash around the injection site immediately after she received PROQUAD (Merck) in August 2013, and was given BENADRYL (dosage unspecified) in office and the rash went away the same day. Additional information is not expected.
No AEs; RN called to report temperature excursion that occurred on 7/12/2022. Caller states that 100 doses of PROQUAD and 94 doses of VARIVAX were administered since 7/12/2022 from mobile unit. No further information provided. No add; This spontaneous report was received from a nurse and refers a child of unknown gender. The patients' concurrent conditions, medical history, allergies and concomitant therapies were not reported.  On 12-JUL-2022, 40 doses of the vaccine varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U029621with expiration date 20-SEP-2023) underwent a temperature excursion during storage.   On an unknown date, the patient was one of 40 patients vaccinated with vaccine varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U029621, expiration date 20-SEP-2023) 0.5 ml once administered as prophylaxis (dose regimen details were not provided).   No adverse event was reported. No further information was reported.  This is one of several reports received from the same reporter.
This spontaneous report was received from a patient's mother refers to her son, a male patient of unknown age. There was no information about pertinent medical history, drug reactions and allergies. On an unknown date, the patient was vaccinated with M-M-R II (lot#, expiration date, dose, frequency, route and site of vaccination were not reported). The mother also specified that her son received the Tdap booster dose on an unspecified date. On an unknown date, the patient experienced a "behavioral reaction" and had become extremely hyperactive since getting the M-M-R II vaccine. The outcome of the event was unknown. The relatedness between the event and M-M-R II was not reported. Additional information has been requested.
Headache/Migraine everyday for about 5 weeks now. Very subtle headache/migraine when I wake up but begins to become more irritating and annoying as day progresses. Days where the headache/migraine is unbearable Fatigue later in the day The past 7 days, my ears having been feeling pressure and the need to pop as if I'm encountering a higher elevation
Pt vaccinated with Meruvax II developed bronchitis, a rash which became itchy.
This spontaneous report was received from a health care worker (reported also as immunization official) and refers to a multiple unspecified patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On an unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M031557 with an expiration date 07-APR-2019 for prophylaxis (doses, route of administration and anatomical location were not reported). There was no adverse effect reported. Administered doses of GARDASIL 9 experienced the temperature excursion from 47 degrees Fahrenheit to 77 degrees Fahrenheit for 1 hour. There was no previous temperature excursion reported. A digital data logger was involved. This is one of several reports received from the same reporter. Additional information is not expected as there was no consent to contact with the physician. Sender's Comments: US-009507513-1705USA008192.
she had a fever; This time her fever has been way worse to the point she hasn't been able to work; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administration date 01May2021 (Batch/Lot number: unknown) at the age of 50 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Her First COVID vaccine was given at (with held), on 08Apr2021 ;lot EW0153.), administration date: 08Apr2021, when the patient was 49 years old, for Covid-19 immunization, reaction(s): "After the first COVID vaccine, she just had pain in her arm, and she had to hold her arm". The following information was reported: PYREXIA (non-serious) with onset 01May2021, outcome "unknown", described as "she had a fever"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 01May2021, outcome "unknown", described as "This time her fever has been way worse to the point she hasn't been able to work". Therapeutic measures were taken as a result of pyrexia, loss of personal independence in daily activities.  Additional information: The Lot for Dose 2 was either EW0170 or EW0179. She took Aleve the first time at maybe 1-2 am. She then woke up and had to work. She took Aleve again at 8 am. Then, an hour after that she took Ibuprofen, 400mg. Her fever was getting really high. No Prior Vaccinations within 4 weeks.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Complained of left temporal headache, getting better (10:50 AM).  Denies skipping breakfast.
When looking at the MCIR I pulled out the Menactra instead of the MMR that should have been given to the patient at the time of the apt. When ordering the injection in the chart I did order MMR and pulled the wrong vaccine and administered this to the patient. I did call the health department right away to find out if this was okay for the patient besides it not counting toward his immunizations since it was done early. I also contacted the patient and spoke with the mother and let my office manager know of the events that occurred .
Vaccines administered 9/10/19 at 3PM. Morning of 9/11/19, inside of left arm pink, by early afternoon of 9/11/19, arm swelling, more pink & worse. Pain about 7 out of 10. Felt hard (approx 4PM) Dr visit on 9/12/19. Prescribed prednisone 20mg Q AM x 5 days, plus hydroxyzine 25mg Q12° for rash. On 9/13/19 redness swelling improved Cleared by 9/16/19
2 days after my booster shot, my arm became very painful.  My first 2 vaccines were pain free.  My arm became so sore I could not extend it and I could not sleep on my right side.  Pain extended into shoulder blade and into my collarbone.  It has been almost 6 months and it is still affecting my daily life and sleep.  Pain is in my arm.  I can pinpoint exactly when injection was given.  Painful rotator cuff, shoulder and pain sometimes goes into my elbow and down to my wrist.
Felt crummy; Sore, my lymph node; Slight headache; Like I was coming down with the cold or flu or something; Like I was coming down with the cold or flu or something; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "Felt crummy"; LYMPH NODE PAIN (non-serious), outcome "unknown", described as "Sore, my lymph node"; HEADACHE (non-serious), outcome "unknown", described as "Slight headache"; NASOPHARYNGITIS (non-serious), INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown" and all described as "Like I was coming down with the cold or flu or something".  Additional information: This was the second case out of 2 cases in which reporter was reporting for herself. Consumer stated that she had some really sharp abdominal pain, she had her shot (Shot name not clarified, hence suspect captured as Unspecified Shot and is this a Pfizer product tab left unchecked), and felt crummy but it was like sore, her lymph node, like a slight headache, like she was coming down with the cold or flu or something but she said she had got really sharp pain in her stomach.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
I received my 5th dose on 09/27/2022. My Sinus infection symptoms started on 12/01/2022 in the morning around 08:00AM. I had a nasal drip, cough, and I was very congested. I thought the symptoms will resolve by itself so I didn't go to the doctor right away. On the 12/12/2022 I went to the clinic since my symptoms wasn't resolving and they prescribed me with antibiotics for 10 days and steroids.
Delayed period by 6 days; Heavy menstrual bleeding; Extended pms symptoms; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169), via an unspecified route of administration in the left arm on 19Apr2021 at 13:00 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Medical history included tonsillectomy, appendectomy and kidney stones. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (ACETAMINOPHEN) for an unknown indication from an unspecified date. The patient's past drug included nitrofurantoin (MACROBID) for an unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, the patient experienced delayed period by 6 days, heavy menstrual bleeding and extended premenstrual syndrome (PMS) symptoms. The clinical outcome of the event delayed period, bleeding menstrual heavy and premenstrual syndrome was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt given TDAP, TYPHOID, H1N1, flu & Hep A/B injections for travel to foreign country. Pt's vaccine finished at 10:15 AM. At 10:50 AM, pt reports nose feeling stopped up & tongue thickness. Pt denies any dyspnea. Dr. administered 9cc BENADRYL (12.5 mg per 5 cc). After 10 mins of taking BENADRYL, pt reports she feels much better and her tongue no longer feels thick. Stayed with pt another 20 minutes & she reported she feels fine now. Pt called me back at 3:00pm 12/2/09 & stated feeling well.
I had a stroke within 3 days of having the 2nd injection that caused loss of half of my eyesight in both of my eyes on the left side only.
Pt had developed a hard, red round lump ring around the injection site.   the site is itchy and warm.    Pt was icing the site.  By the next day, the ring has gotten bigger.  Pt went to the the doctor by 3rd day and was given cephalexin.
Information has been received from a nurse concerning a 42 year old female who on 13-JAN-2011 was vaccinated with a dose of PNEUMOVAX 23 (lot no. 665401/1320Y) 0.5mL. On 13-JAN-2011, 3 hours after vaccination, the patient experienced pain, numbness and tingling in the arm with injection site. The patient also reported having a slight buildup of fluid in same arm the following day. No treatment was given. On 18-JAN-2011, the patient recovered from the symptoms. The patient sought unspecified medical attention. Additional information has been requested.
Red welt with 1 cm induration, pimple-like lesion to site x 2 days after injection. Pt. developed rash to arms, abdomen, and face 9-10 days after vaccination. Afebrile, non-fussy.
really dizzy sitting and standing; laid down and was dizzy; a little nauseous but didn't vomit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS POSTURAL (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "really dizzy sitting and standing; laid down and was dizzy"; NAUSEA (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "a little nauseous but didn't vomit".  Additional Information: The reporter/patient was pretty good at time of report but wanted to know if that was an effect of the vaccine and if this dizziness was normal, 30 hours after the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Tingling and weakness in extremities, airway tightening, nausea, extreme fatigue. Symptoms came in waves approximately 5 minutes apart. Administration of Zofran, Prednisone and Benadryl.
Information was received on 17APR2014 from an employee on behalf of five consumers. This is case 2 of 5. On 11MAR2014 a consumer (age / gender unspecified) received immunization with BIOTHRAX (lot FAV365). Subsequently the individual experienced hypertension, chest tightness and a bloody nose which led to hospitalization. The reporter requested that the product be tested for possible contamination. No further information provided. Further information has been requested.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. In approximately November 2012 the patient was vaccinated with first dose of GARDASIL (dose and route of administration were not reported). On an unknown date the patient who received her first dose of GARDASIL two years ago came into the office on 07-NOV-2014 (reported as "today") to receive second dose of GARDASIL. No adverse effects reported. Additional information has been requested.
Patients arm feels heavy to where he has to use his other arm to lift it. The vaccine was administered on 1-19-11 and pt is still having pain and can't lift arm.
several days following immin on 28Dec89, pt devel tingling in the extremities, later devel ascending flaccid motor paralysis & loss of deep tendon reflexes.Hospitalized, Guillain-Barre synd was dx & sequelae reportedly persist.
Headache; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Half of face paralyzed. Diagnosed with Bells Palsy 5 days after receiving vaccine.  12/09/09 ED notes for DOS 11/24/09.  DX: Bell's palsy.  Pt c/o L facial numbness and R decreased motion, migrating aches and pain.  On examination: slight R facial droop. Neuro exam: intact sensory and motor.
runny nose; sore throat; body ache; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 27-year-old female patient received BNT162b2 (BNT162B2), on 04Nov2021 as dose 3 (booster), single (Lot number: EL0140) at the age of 27 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: pfizer covid vaccine (Dose Number: 2, Batch/Lot No: EL3302), administration date: 21Feb2021, when the patient was 26-year-old, for COVID-19 Immunization; pfizer covid vaccine (Dose Number: 1, Batch/Lot No: EL0140), administration date: 12Jan2021, when the patient was 26-year-old, for COVID-19 Immunization. The following information was reported: PAIN (non-serious) with onset 12Jun2022, outcome "not recovered", described as "body ache"; RHINORRHOEA (non-serious) with onset 12Jun2022, outcome "not recovered", described as "runny nose"; OROPHARYNGEAL PAIN (non-serious) with onset 12Jun2022, outcome "not recovered", described as "sore throat". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of rhinorrhoea, oropharyngeal pain, pain.  Additional information: The patient did not have COVID prior vaccination. COVID was tested post vaccination.
sore arm; did not get second shot; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Coronary artery disease.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm) (seriousness criterion hospitalization) and PRODUCT DOSE OMISSION ISSUE (did not get second shot). At the time of the report, MYALGIA (sore arm) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (did not get second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was mentioned by reporter  No treatment medication information was mentioned by reporter.  Company comment: This case concerns a 60-year-old, female patient with relevant medical history of coronary artery disease, who experienced the expected event of Myalgia and unexpected event of Product dose omission. The event of Myalgia occurred on an unknown date and the patient did not receive the second dose of the Moderna Covid-19 vaccine. The rechallenge was not applicable, as the event of Myalgia happened after the first dose. The events were considered related to the product per the reporter's assessment. The event of Myalgia is consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of Moderna Covid-19 vaccine is not affected by this report.; Sender's Comments: This case concerns a 60-year-old, female patient with relevant medical history of coronary artery disease, who experienced the expected event of Myalgia and unexpected event of Product dose omission. The event of Myalgia occurred on an unknown date and the patient did not receive the second dose of the Moderna Covid-19 vaccine. The rechallenge was not applicable, as the event of Myalgia happened after the first dose. The events were considered related to the product per the reporter's assessment. The event of Myalgia is consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of Moderna Covid-19 vaccine is not affected by this report.
PT experienced difficulty breathing and swallowing and felt like her throat was closing within 5 minutes of vaccination. Epinephrine given and 911 Dispatch called.  She was monitored with care.
patient had onset of Bell's Palsy 1 week following her vaccine, reports that her husband also had numbness and tingling to his extremities
Face got red 15 min after vaccine given 7/23/15. Hands, feet, private areas felt hot. Occurred day after vaccine as Nov 9:00 am.
Lost taste; Next day her taste changed; Food tastes bitter/water tastes sweet; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost taste), TASTE DISORDER (Next day her taste changed) and DYSGEUSIA (Food tastes bitter/water tastes sweet) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced AGEUSIA (Lost taste), TASTE DISORDER (Next day her taste changed) and DYSGEUSIA (Food tastes bitter/water tastes sweet). At the time of the report, AGEUSIA (Lost taste), TASTE DISORDER (Next day her taste changed) and DYSGEUSIA (Food tastes bitter/water tastes sweet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Patient reported syncopal episode at 2AM on 01/28/21.  Per patient, she woke up feeling naseaus went to bathroom became faint when she turned on the light and passed out.  Per patient she believes she hit her head on the bathroom since.  1x1.5 inch bruised are noted to left forehead.  Per patient she was seeing a bright spot and blurry vision to left eye for 45 minutes following the fall.  At time of assessment patient experiencing mild headache and fatigue.  Patient took 600mg ibuprofen at 4AM.
I noticed on 06/13/2022 that I had really pronounced allergies, slight sore throat, and nasal drip. The next day, it got worse so I took my temperature around 4pm; my temperature was 99.1F that evening. I took an at-home COVID-19 rapid antigen test, and it came back negative. So on 06/15/2022, I didn't take a test until around midnight that my fever rose to 100.5F. I then knew it wasn't a sinus infection and had to be COVID-19. That next morning, I went to an urgent care where they tested me for COVID-19 and two strands of influenza. Only the COVID-19 test came back positive; the doctor prescribed me prednisone, azithromycin, and benzonatate. I only took the prednisone and azithromycin for the 5-day prescription course. As of now, I feel better but still have some mild congestion at times and blurry vision. So I take I might have some long-term COVID-19 symptoms. In addition, I have some slight brain fog as well.
client reported 2 hrs after vaccine had syncope episode lasting a few seconds. Per client fell and hit head. Client stated followed up with medical provider.
Injection hurt going in and needle coming out., it was given in my Left upper arm very high. Has hurt ever since.  Arm has hurt lifting arm up to put tee shirt on and when I cross over my Left arm to the right.  Pain has decrease about 75%. I can still feel discomfort on the upper inward side of arm and at injection site. I took naproxen for 10 days at night, helped some. Used heat some I have continued my everyday activities. I feel using it would be better.